Subscribe: Barron's Most Viewed Today
Added By: Feedage Forager Feedage Grade B rated
Language: English
analyst  barron viewed  company  drug  higher  life  margins  nike  qorvo  revenue  sales  sarepta  shares  skyworks  viewed today   
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Barron's Most Viewed Today

Barron's Most Viewed Today

Barron's Most Viewed Today

Last Build Date: Fri, 21 Jul 2017 02:56:18 EDT

Copyright: copyright © 2017 Dow Jones & Company, Inc.

Sick of Chipotle? Analyst Suggests a Different Chain

Thu, 20 Jul 2017 16:56:04 EDT

Del Taco Restaurants is introducing changes that could boost its stock price.image

Media Files:

Nike: The Steph Curry Threat Is Fading Away

Thu, 20 Jul 2017 16:50:32 EDT

After a difficult past couple of years for Nike’s stock, an analyst sees brighter skies ahead.image

Media Files:

Nike Can Do It --- Again

Thu, 20 Jul 2017 17:26:41 EDT

After two years of flattish trading, shares of Nike have sprung to life and are “set to appreciate quickly,” says Morgan Stanley’s Jay Sole. image

Media Files:

Twitter: Signs of Life Before Earnings Season

Thu, 20 Jul 2017 17:49:39 EDT

The social media company appears to be having success with video advertising.image

Media Files:

Qorvo Seen Preferred to Skyworks

Thu, 20 Jul 2017 15:15:27 EDT

Qorvo may drive outsized revenue growth and margins higher over the midterm yet it trades to a discount to Skyworks.image

Media Files:

Bill Gross Frets About a Fragile Economy

Thu, 20 Jul 2017 13:51:25 EDT

The famed fund manager warns Fed that it won’t take a large rise in short-term rates to trigger a recession. image

Media Files:

Frontier Communications Could Cut Guidance

Thu, 20 Jul 2017 13:04:35 EDT

It may not be surprising to see the company revise 2017 guidance lower as soon as Q2 results on Aug. 1.image

Media Files:

Sarepta Can Rally Further As Key Drug Gains Sales

Fri, 21 Jul 2017 00:20:24 EDT

Shares surged 20% Thursday after Sarepta reported strong sales of its DMD drug and raised its forecast.image

Media Files:

Alibaba, JD Battle Pressures Margins

Thu, 20 Jul 2017 11:08:13 EDT

The rivalry will hurt Alibaba’s EPS, although the outlook for both remains positive. JD could see higher revenue.image

Media Files:

As Altaba Winds Down Yahoo!'s Holdings, Shares Could Post 20% Gain

Sat, 01 Jul 2017 03:54:23 EDT

The shares still offer “a lot of ways to win,” says one analyst.